It has been more than twenty years since the collapse of the World Trade Center on September 11th, 2001. Dr. Slavin discusses Myriad Genetics’ company-wide involvement in the effort to help identify victims of the tragedy with John Ryan, Sr. VP of Operations, Women’s Health and Oncology, and Benoît Leclair, Program Director of Quality Assurance and Regulatory Affairs.